U.S. House Calls Industry Overview
The U.S. house calls market size is expected to reach USD 831.2 million by 2030 expanding at a CAGR of 5.62%, based on a new report by Grand View Research, Inc. Advanced healthcare technology and medical devices have enabled house call practices to provide continuous coordinated care to patients in a convenient location at affordable prices. Home visits have enabled physicians to make data-driven and informed decisions regarding the diagnosis and treatment of individual patients.
The adoption of house call services by patients not only provides them with optimum care at their home but also has other benefits. A provider of house calls, Heal, estimated that its house call services reduced hospitalization rate by 28% and unnecessary urgent care and emergency room visits by up to 71%, saving around USD 53.7 million annually.
The COVID-19 pandemic further boosted app-based house call services, as it was the only option during the pandemic restrictions and a safe one to avoiding avoid the risk of infection at the hospitals. These services are reducing hospitalization time for patients, and saving costs for them, especially for long-term chronic care.
The competition among market players is very high. Launch of new mobile apps to ease the process of requesting house calls, collaborating with other players to gain access to patient data, and acquisitions to increase market presence are leading to high competition in the market.
U.S. House Calls Market Segmentation
Grand View Research has segmented the U.S. house calls market based on service:
Based on the Service, the market is segmented into Primary Care, Urgent Care, Preventive Care, Mobile Clinical Testing, Chronic Care Management, and Others.
- The service segment is categorized into primary care, urgent care, preventive care, mobile clinical testing, chronic care management, and others. In 2022, the primary care segment held the largest market share of 26.45% in terms of revenue and is expected to witness the highest growth with a CAGR of 6.04% during the forecast period.
- Patients with chronic medical conditions – such as diabetes, Parkinson’s disease, Alzheimer’s disease, and Chronic Obstructive Pulmonary Disease (COPD) among others – require medical care regularly. Such people might not always be able to visit medical centers and may require frequent care which is leading to the high demand for house call services for chronic care management.
Key Companies & Market Share Insights
The U.S. house calls market is highly competitive. The top players are adopting various strategies, such as market expansion, mergers & acquisitions, and partnerships to strengthen their presence in the market. For Instance, in March 2021, Heal announced a partnership with Medley Pharmacy to help patients access critical prescriptions and medication without leaving home. Some of the prominent players in the U.S. house call market include:
- SOS Doctors House Calls, Inc
- Heal
- Doctor on Demand, Inc
- Resurgia Health Solutions LLC
- MDLIVE, Inc
- House Call Doctors Loss Angeles
- Mount Sinai Visiting Doctors
- Visiting Physician Association
- Urgent Med Housecalls
- House Call Doctors Medical Group
Order a free sample PDF of the U.S. House Calls Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com